185 related articles for article (PubMed ID: 7535092)
1. Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression.
Langerak AW; Williamson KA; Miyagawa K; Hagemeijer A; Versnel MA; Hastie ND
Genes Chromosomes Cancer; 1995 Feb; 12(2):87-96. PubMed ID: 7535092
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
Amin KM; Litzky LA; Smythe WR; Mooney AM; Morris JM; Mews DJ; Pass HI; Kari C; Rodeck U; Rauscher FJ
Am J Pathol; 1995 Feb; 146(2):344-56. PubMed ID: 7856747
[TBL] [Abstract][Full Text] [Related]
3. Splicing of the platelet-derived-growth-factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression.
Langerak AW; Dirks RP; Versnel MA
Eur J Biochem; 1992 Sep; 208(3):589-96. PubMed ID: 1396665
[TBL] [Abstract][Full Text] [Related]
4. Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes.
Rodeck U; Bossler A; Kari C; Humphreys CW; Györfi T; Maurer J; Thiel E; Menssen HD
Int J Cancer; 1994 Oct; 59(1):78-82. PubMed ID: 7927908
[TBL] [Abstract][Full Text] [Related]
5. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
6. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
[TBL] [Abstract][Full Text] [Related]
7. Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines.
Langerak AW; van der Linden-van Beurden CA; Versnel MA
Biochim Biophys Acta; 1996 Feb; 1305(1-2):63-70. PubMed ID: 8605252
[TBL] [Abstract][Full Text] [Related]
8. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
Guan LS; Liu JJ; Xu YH; Wang ZY
Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
[TBL] [Abstract][Full Text] [Related]
9. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
Roberts DJ; Haber D; Sklar J; Crum CP
Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
11. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
[TBL] [Abstract][Full Text] [Related]
12. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
[TBL] [Abstract][Full Text] [Related]
13. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
Hewitt SM; Saunders GF
Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
[TBL] [Abstract][Full Text] [Related]
14. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.
Duarte A; Caricasole A; Graham CF; Ward A
Br J Cancer; 1998; 77(2):253-9. PubMed ID: 9460996
[TBL] [Abstract][Full Text] [Related]
17. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene.
Wang ZY; Madden SL; Deuel TF; Rauscher FJ
J Biol Chem; 1992 Nov; 267(31):21999-2002. PubMed ID: 1429549
[TBL] [Abstract][Full Text] [Related]
18. Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1.
Ward A; Pooler JA; Miyagawa K; Duarte A; Hastie ND; Caricasole A
Gene; 1995 Dec; 167(1-2):239-43. PubMed ID: 8566784
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
20. Functional properties of WT1.
Haber DA; Englert C; Maheswaran S
Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
